Filing Details
- Accession Number:
- 0001649094-24-000091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-04 18:46:45
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-11-04 18:46:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1258693 | Grant Pickering | C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-01 | 9,955 | $106.35 | 440,264 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-01 | 3,312 | $107.34 | 436,952 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-01 | 1,733 | $108.50 | 435,219 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 138,581 | Indirect | By Children's Trust |
| Common Stock | 138,581 | Indirect | By Children's Trust |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $105.855 to $106.80. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $106.865 to $107.845. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $107.97 to $108.93. The reporting person will provide upon request to the SEC, the issuer or security holder of theissuer, full information regarding the number of shares sold at each separate price.
- Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
- Shares are held directly by a trust for the benefit of the Reporting Person's son.
Billionaire Hedge Funds
